01.20.25 -- Lessons In Automation With Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

To ensure the success of gene therapy, learn why it is crucial to partner with a CRO that can navigate the challenges of viral vector development and testing.

The Cryoport Elite shipping system sets a new standard for the transport of sensitive biopharmaceuticals. Explore its pioneering features and industry impact with Mike Dybicz, SVP & CPDO at Cryoport Systems.

Explore how two-column AAV processes can enhance yield and potency while maintaining high-quality standards in the production of gene therapy products.

Augmented reality enables drug sponsors to provide remote assistance and direction to their manufacturing team during tech transfer and improving the effectiveness of manufacturing processes.

See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production.

The need for greater volumes of high-quality raw materials like plasmid DNA in the cell and gene therapy space has made pDNA standardization integral to streamlining the development process.

Low AAV productivity and lack of platform processes continue to be key challenges driving AAV production cost up. Explore a robust and scalable suspension manufacturing platform for AAV production.

Optimize your mRNA production with an advanced IVT process, enhancing scalability, purity, and expression activity for clinically relevant RNA therapeutics.

Allogeneic therapies leverage donor cells to ensure optimal starting material and ensure patients can receive treatment without delays, ultimately helping to improve safety and expand patient access.